top of page
Search

Blood Plasma Derivatives Market Trends, Opportunities, Top Companies 2027

Writer: celina reddencelina redden

Blood Plasma Derivatives Market Research Report: Information by Type [Factor VIII Concentrate, Factor IX Concentrate, Albumin, Immune Globulins, Anti-Thrombin III Concentrate, and Fresh Frozen Plasma (FFP)], Application (HIV, Hemophilia A, Hemophilia B, Hepatitis B, Hepatitis C, Bleeding Disorders, Hypogammaglobulinemia, Immunodeficiency Diseases, and Others), End User (Hospitals & Clinics, Blood Transfusion Centers, Diagnostic Centers, and Others), and Region (Americas, Europe, Asia-Pacific, and Middle East & Africa)—Forecast till 2027

Global Blood Plasma Derivatives Market – Competitive Analysis

Grigols (Spain), Baxter International Inc. (US), Octapharma AG (Switzerland), CSL Limited (Australia), Kedrion S.p.A (Italy), Bain Capital, LLC (US), Biotest AG (Germany), Fusion Healthcare (India), SK Plasma Co., Ltd. (South Korea) are some of the prominent players at the forefront of competition in the blood plasma derivatives market and are profiled in MRFR Analysis.

Global Blood Plasma Derivatives Market is currently dominated by few players.

Grigols is one of them by holding a strong share in the market. The company’s stronghold is largely attributed to its innovative and sustainable products. Grigols aoperates in three major divisions i.e. Bioscience, Diagnostic and Hospital. On November 17, 2017 Grigols received FDA approval for a new genetic test used to detect alpha-1 antitrypsin deficiency. On November 11, 2013, Grifols acquired blood transfusion testing unit of Novartis AG for USD 1.68 billion. In the year 2016, Grifols has also acquired NAT (Nucleic Acid Testing) donor screening unit of Hologic for USD 1,850 million.

Baxter is also one of the leading player in Blood Plasma Derivatives Market Baxter International Inc., the US based biopharmaceutical company, operates in two major segments, i.e. Hospital Products and Renal. Baxter’s product Bebulin (Factor IX Complex) is specifically used for the prevention, of hemorrhagic episodes in case of hemophilia B. Bebulin may carry a risk of transmitting infectious agents, such as viruses and, Creutzfeldt‐Jakob disease (CJD) agent.

On July 27, 2017, Baxter International Inc. completed the acquisition of Claris Injectables Limited for approximately USD 625 million. The main motive of acquisition is the expansion of generic pharmaceuticals.

On June 06, 2017, ADMA Biologics, Inc., a biopharmaceutical company, has acquired therapy business unit of Biotest Pharmaceuticals. As a result of this, ADMA acquired two FDA approved products ie Nabi-HB ™, and and BIVIGAM ™.

Regional Analysis of Blood Plasma Derivatives Market:

Globally, Blood Plasma Derivatives market consists of four regions North America, Europe, Asia-Pacific and Middle East and Africa.

North America is the largest market for syringe and needle. The North American market for Blood Plasma Derivatives is expected to grow at a CAGR of 4.25% which is expected to reach at US $ 35.50 billion from US $ 20 billion in 2016 by the end of the forecasted period.

Awareness regarding use of plasma derivatives for patients suffering from infectious diseases drive this market in North America. Europe is the second-largest market for Blood Plasma Derivatives which is expected to grow at a CAGR of 3.8%. Extensive research on safe blood transfusion in healthcare organizations and research laboratories favor the growth of this market in Europe.

Whereas Asia Pacific is expected to be the fastest growing market for Blood Plasma Derivatives market. India is expected to be the emerging and fastest growing market. Demand for plasma derivatives for inactivation of HIV favor the demand of plasma derivatives in Asia-Pacific. The market shows steady growth in Middle East and Africa.

About Market Research Future:

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 
 
 

Recent Posts

See All

Comentarios


bottom of page